Leading by example

Executive Team

CEO, Innovation Business
Dr. Alessandro Riva, M.D.
+
CEO, Innovation BusinessDr. Alessandro Riva, M.D.

Dr. Alessandro Riva, M.D. joined Glenmark’s new Innovation Company in April, 2019 to lead the company as Chief Executive Officer. 

Most recently, Alessandro was Executive Vice President, Global Head of Hematology and Oncology Therapeutics for Gilead.  In addition, he was appointed head of the Gilead’s Cell Therapy organization, a role that included oversight of Kite Pharma and Cell Design Labs.  Prior to joining Gilead, he was Global Head of Oncology Development at Novartis Pharmaceuticals from 2005 to 2016 where he was responsible for the global development and registration of more than 30 oncology compounds, including targeted and immuno-oncology therapies. Alessandro was President at Interim of the Oncology Business Unit at Novartis from January 2016 to June 2016.

An Oncologist/Hematologist by training, Dr. Riva received his bachelor’s degree in medicine from the Università degli Studi di Milano in 1986 and a Certificate Board in Oncology/Hematology from the same institution in 1989.  He began his career at Famitalia Carlo Erba, where he developed and registered epidoxorubicin in various solid tumors and idarubicin in acute myeloid leukemia. He later moved to clinical development leadership positions within Rhône-Poulenc Rohrer and Aventis.

Dr. Riva co-founded the Breast Cancer International Research Group (BIRG), a global nonprofit cooperative group, and Cancer International Research Group (CIRG), a global clinical research organization, for which he served as Chief Executive Officer and Chief Medical Officer. He has authored or co-authored more than 100 papers and abstracts in the field of Oncology.

Dr. Riva is a member of the American Society of Clinical Oncology and the European Society for Medical Oncology.

President & Chief Medical Officer
Dr. Mahboob Rahman, MD PhD
+
President & Chief Medical OfficerDr. Mahboob Rahman, MD PhD

Dr. Mahboob Rahman is the President & Chief Medical Officer at Glenmark Pharmaceuticals and oversees Global Clinical Sciences, Portfolio and Program Management, Global Clinical & Pharmacovigilance Quality Assurance, Regulatory Affairs and Drug Metabolism and Pharmacokinetics. He has more than 30 years of clinical practice and research experience, as well as teaching experience at three medical schools (Harvard, University of Pennsylvania, and Rutgers/Robert Wood Johnson). He has authored more than a hundred scientific papers and book chapters. Dr. Rahman most recently served as Vice President & Therapeutic Area Head for Immunology in Global Clinical Development at Novartis. Prior to Novartis, he has worked with Centocor/Johnson & Johnson and Pfizer. During his tenure at these 3 companies, he was involved in the approval of a number indications for multiple compounds. Dr. Rahman holds the Medical Degree from Dhaka Medical College and a Ph.D. in Molecular Biology, from the Medical College of Pennsylvania. He completed his Internal Medicine Residency at the Medical College of Pennsylvania, and Rheumatology Fellowship training at Massachusetts General Hospital/Harvard Medical School.  He then served as an Instructor in Medicine at the Harvard Medical School. At the University of Pennsylvania, he served as an Adjunct Professor of Medicine for Rheumatology. Dr. Rahman is a US Board Certified Rheumatologist and continues to be a practicing physician at Rutgers/Robert Wood Johnson School of Medicine where he is also a Clinical Professor of Medicine for Rheumatology.

President and Global Chief Financial Officer
Mr. V. S. Mani
+
President and Global Chief Financial OfficerMr. V. S. Mani

Mr. V. S. Mani is President and Global Chief Financial Officer of Glenmark Pharmaceuticals Ltd. He is responsible for the company’s worldwide finance operations and secretarial function, including global accounting, financial reporting, tax and treasury functions. He has over 25 years of rich industry experience across treasury, taxation (direct, indirect & international), accounting, financial planning & analysis, secretarial, legal, audits (internal & statutory), risk management and investor relations.

Prior to joining Glenmark in 2017, he was the President Finance at the Bhartiya Group. He has also held the position of the Chief Financial Officer at Cipla and played a key role in acquisition of various companies in emerging and mature markets for the organization. He is a qualified Chartered Accountant.

President, North America
Mr. Robert Matsuk
+
President, North AmericaMr. Robert Matsuk

Mr. Robert Matsuk is President of North America at Glenmark Pharmaceuticals Ltd. He has overall responsibility for the company’s generics and branded pharmaceutical business across North America. Prior to joining Glenmark in 2014, he was Executive Vice President and Chief Strategy Officer at HighPoint Solutions where he had overall responsibility for the Life Sciences business. Mr. Matsuk also held other senior leadership positions within the Life Sciences industry at PricewaterhouseCoopers and Computer Sciences Corporation. He received his Masters in Business Administration from Northwestern University’s J.L. Kellogg Graduate School of Management and graduated from the Philadelphia College of Pharmacy and Science with a Bachelor’s of Pharmacy degree.

President, India Formulations & MEA (Middle East & Africa) Region
Mr. Sujesh Vasudevan
+
President, India Formulations & MEA (Middle East & Africa) RegionMr. Sujesh Vasudevan

Mr. Sujesh Vasudevan is Glenmark’s President, India Formulations and the Middle East & Africa (MEA) regions. He has overall responsibility of the company’s generics and branded pharmaceutical businesses across India, Middle East and Africa.  Prior to joining Glenmark in 2013, he served as Director of Sales & Marketing at Abbott India Limited. Mr. Vasudevan has completed the Advanced Management Program from Harvard Business School. He has also received a Master's degree in Management Studies from K J Somaiya Institute of Management Studies & Research and holds a Bachelor’s degree in Pharmacy from KM Kundnani College of Pharmacy, Mumbai.

President and the Global Head of Operations
Mr. Kanish Malik
+
President and the Global Head of OperationsMr. Kanish Malik

Mr. Kanish Malik is President and Global Head of Operations at Glenmark Pharmaceuticals Ltd. In his role, he oversees the operations of 16 manufacturing facilities spread across 4 continents that produce branded & generic medicines as well as active pharmaceutical ingredients. He also manages the global supply chain for the organization.

Mr. Malik has over 30 years of industry experience in operations, supply chain management and leading large sophisticated manufacturing & service-oriented organizations.

Prior to joining Glenmark in 2015, Mr. Malik had worked with PepsiCo & Unilever and held wide range of roles in India as well as the Asia Pacific Region. He holds a bachelor's degree in Chemical Engineering from Punjab University, India.

President & Global Chief Human Resources Officer
Mr. Jayaram Philkana
+
President & Global Chief Human Resources OfficerMr. Jayaram Philkana

Mr. Jayaram Philkana is the President and Global Chief Human Resources Officer at Glenmark Pharmaceuticals Ltd. He is responsible for managing the organization’s diverse global talent including Talent acquisition, Performance and Rewards, Leadership development, Employee relations and all the other aspects of human resources strategies. Prior to joining Glenmark, he was the Global CHRO at  UPL Ltd. since 2014.  Mr. Philkana has previously worked with Cargill for over 18 years and has held a wide range of leadership roles in the US, Asia Pacific and South East Asia Region. Earlier in his career, he had brief stints with PWC, Smithkline Beecham and British American Tobacco. He holds a master’s degree in Business Administration with a specialization in Human Resources from XLRI Jamshedpur, India.

President, Global Quality
Dr. Darshan Makhey
+
President, Global QualityDr. Darshan Makhey

Dr. Darshan Makhey is President, Global Quality at Glenmark Pharmaceuticals Ltd. In this role he has the critical responsibility of protecting and enhancing Glenmark’s reputation for high-quality and reliable products across a variety of disease states. Dr. Makhey has over 20 years of experience in the industry. He has served in a variety of strategic leadership and executive roles, with increasing responsibility across multiple organizations including quality and compliance. Prior to joining Glenmark in 2012, he was Head of Global Quality at Dr. Reddy's Laboratories Ltd. He received a PhD in Medicinal Chemistry from Rutgers, The State University of New Jersey.

President & Global Head - Legal and Corporate Affairs
Mr. Kaizad Adi Hazari
+
President & Global Head - Legal and Corporate AffairsMr. Kaizad Adi Hazari

Mr. Kaizad Adi Hazari is the President & Global Head of Legal and Corporate Affairs at Glenmark Pharmaceuticals. In this role, he leads  the Corporate Affairs, Legal and Intellectual Property functions globally. Mr. Hazari has over twenty five years of rich experience across industries. Prior to joining Glenmark, he was with HDFC Limited as the Chief Executive Officer for their new businesses. He has also worked with GlaxoSmithKline Pharmaceuticals Ltd (GSK) as Executive Vice President (South Asia) handling Legal and Corporate Affairs functions. In his last assignment at GSK, he was the Vice President & Associate General Counsel - Emerging Markets including the Middle East, North Africa and CIS regions as well as countries such as Turkey, Russia, Kenya and Nigeria. Mr. Hazari has earlier worked in companies such as Hindalco and Asian Paints. He holds a Master’s degree in law from Mumbai University.